Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK3 | O43781 | 1/20 | 0.34 |
| ▸ | CLK1 | P49759 | 1/20 | 0.34 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.34 |
| ▸ | DYRK4 | Q9NR20 | 1/20 | 0.34 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 10/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 10/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 10/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30948888 | 0.87 | TP53 (0.36) | ADORA1ADORA3 | |
| SCHEMBL30997368 | 0.83 | KCNH3 (0.34) | — | |
| SCHEMBL30948894 | 0.83 | RXFP1 (0.37) | — | |
| SCHEMBL30997365 | 0.82 | PDE2A (0.33) | — | |
| SCHEMBL30997398 | 0.81 | KCNH3 (0.32) | — | |
| SCHEMBL31030126 | 0.81 | — | — | |
| SCHEMBL31030127 | 0.81 | — | — | |
| SCHEMBL31030155 | 0.80 | KCNN1 (0.38) | — | |
| SCHEMBL31010618 | 0.80 | TLR7 (0.30) | TLR7 | |
| SCHEMBL31030122 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4651950-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | Skyhawk Therapeutics, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| WO-2024155842-A1 | COMPOSITIONS USEFUL FOR MODULATING SPLICING | SKYHAWK THERAPEUTICS, INC. (US) | 2024-07-25 | — | — | WO | disclosed |